For a better experience, click the icon above to turn off Compatibility Mode, which is only for viewing older websites.
January 23, 2015
January 19, 2015
Jim currently serves as the CEO of PolyCore Therapeutics, a spin-out from Drexel University, focused on the development of a treatment for Parkinson’s Disease. Jim is also the CEO of LignaMed, LLC a spin-out from the University of Pennsylvania, focused on the development of an agent to improve outcomes in the treatment of chest Mr. Harris is the Co-founder and COO of FHK LLC, a company focused on acquisition and commercialization of specialty pharmaceutical products.